Advancements in Hormone Receptor-Positive Metastatic Breast Cancer

home / expertconnections / advancements-in-hormone-receptor-positive-metastatic-breast-cancer

Virginia Kaklamani, MD, DSc; and Megan Kruse, MD, discuss how advances in hormone receptor-positive metastatic breast cancer treatment, including ESR1 mutation testing and elacestrant therapy, help physicians optimize patient care and improve outcomes through personalized treatment selection.

2 experts are featured in this series.

EP. 1: Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment

Virginia Kaklamani, MD, DSc;Megan Kruse, MD
May 1st 2025

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer.

Watch